Janjigian, Y. Y., Shitara, K., Elimova, E., Zhang, J., Chen, M., Smyth, E. C., Lee, J., Miao, R., Liu, S., Holmblad, M., Xu, R. (2025). CLARITY-Gastric 01: A randomized phase 3 study of AZD0901, a Claudin18.2 (CLDN18.2)-targeted antibody-drug conjugate, in second- or later-line (2L+) advanced gastric or gastroesophageal junction cancer (GC/GEJC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.tps507